streptokinase

Purpose To evaluate the efficacy and safety of intravenous recombinant streptokinase ( r-SK) in treatment of patients with acute deep veinous thrombosis of the lower limbs ( ADVT).

目的观察国产重组链激酶（rSK）对下肢急性深静脉血栓形成的疗效和安全性。

Effect on blood coagulation function and toxicity of recombinant streptokinase in rats

重组链激酶对大鼠凝血功能的影响及其毒性

For patients with acute ischemic stroke, we recommend against streptokinase ( Grade 1 A ).

急性缺血性卒中患者, 推荐不用链激酶 ( 1A级 ).

To test this hypothesis, we evaluated the effect of low-dose intracoronary streptokinase administered immediately after PCI.

为了检验该假说, 我们评估在首次经皮冠脉介入后立即冠状动脉内注射低剂量的链激酶的效果.

Commonly used thrombolytic drugs contant Streptokinase, Urokinase ( UK), Recombinant tissue type plasminogen activator ( rt-PA), Vermis kinase, Batroxobin, Reteplase etc, UK in especial.

常用的溶栓药物有：链激酶、尿激酶（urokinase，UK）、重组组织型纤溶酶原激活物（rt-PA）、蚓激酶、巴曲酶、瑞替普酶等，其中以UK最为常用。

Intrapleural streptokinase for pleural infection A step forward in managing pleural effusions?

胸膜腔内滴注链激酶治疗胸膜腔感染这是胸膜腔积液治疗的进步 吗 ?